Tg(Prnp-TARDBP*Q331K)31Dwc
Transgene Detail
|
Symbol: |
Tg(Prnp-TARDBP*Q331K)31Dwc |
Name: |
transgene insertion 31, Don W Cleveland |
MGI ID: |
MGI:5825215 |
Synonyms: |
TDP-43Q331K line 31 |
Transgene: |
Tg(Prnp-TARDBP*Q331K)31Dwc Location: unknown
|
Alliance: |
Tg(Prnp-TARDBP*Q331K)31Dwc page
|
|
Strain of Origin: |
C57BL/6 x C3H
|
|
Transgene Type: |
|
Transgenic (Humanized sequence, Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(Prnp-TARDBP*Q331K)31Dwc expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
TARDBP (23435) |
|
contains a Q331K substition |
|
|
|
Mutation details: A full-length human TAR DNA binding protein (TARDBP or TDP-43) cDNA sequence was modified to have both an N-terminal myc tag and the glutamine to lysine substitution at amino acid 331 associated with familial ALS (huTDP-43*Q331K). This huTDP-43*Q331K cDNA sequence was inserted between exon 2 and exon 3 of mouse prion protein (Prnp) gene. The resulting Prnp-TDP-43*Q331K transgene was flanked with loxP sites. Founder line 31 has moderate overexpression levels in total TDP-43 mRNA/protein, with an ~3-fold increase in total TDP-43 expression (huTDP-43*Q331K levels ~2-fold greater) compared to endogenous TDP-43 in non-transgenic mice.
(J:191785)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:191785 Arnold ES, et al., ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):E736-45 |
All: |
3 reference(s) |
|